Comparison of long-term outcomes of young patients after a coronary event associated with familial hypercholesterolemia-Reference-Cited by-同舟云学术

Comparison of long-term outcomes of young patients after a coronary event associated with familial hypercholesterolemia

Published:2019-06-01 Issue:1 Volume:18 Page:
ISSN:1476-511X
Container-title:Lipids in Health and Disease
language:en
Short-container-title:Lipids Health Dis

Author:

Wang Xu,Cai Gaojun,Wang Yingying,Liu Ran,Xi Ziwei,Li Gexuan,Wen Wenhui,Wu Yue,Wang Chenggang,Ji Qingwei,Wang Xinguo,Zhang Qian,Zeng Yujie,Wang Luya,Liu Wei,Zhou Yujie

Funder

Chinese Cardiovascular Association-Access found

Chinese Cardiovascular Association-V.G found

Municipal Science and Technology Commission of Beijing

National Key Research and Development Program of China

Beijing Municipal Administration of Hospitals Ascent Plan

Beijing Municipal Health Commission “Project of Science and Technology Innovation Center”

Beijing Municipal Administration of Hospitals Mission plan

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/s12944-019-1074-8.pdf

Reference22 articles.

1. Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, Bruckert E, Defesche J, Lin KK, Livingston M, Mata P, Parhofer KG, Raal FJ, Santos RD, Sijbrands EJ, Simpson WG, Sullivan DR, Susekov AV, Tomlinson B, Wiegman A, Yamashita S, Kastelein JJ. Integrated guidance on the care of familial hypercholesterolaemia from the international FH Foundation. Int J Cardiol. 2014;171(3):309–25. 24418289 .

2. Nordestgaard BG,Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG, Hovingh GK, Kovanen PT, Boileau C, Averna M, Borén J, Bruckert E, Catapano AL, Kuivenhoven JA, Pajukanta P, Ray K, Stalenhoef AF, Stroes E, Taskinen MR, Tybjærg-Hansen A; European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European atherosclerosis society. Eur Heart J 2013, 34: 3478-3490a. [PMID: 23956253].

3. Austin MA, Hutter CM, Zimmern RL, Humphries SE. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol 2004, 160(5): 407–420. [PMID: 15321837].

4. Shi Z, Yuan B, Zhao D, Taylor AW, Lin J, Watts GF. Familial hypercholesterolemia in China: prevalence and evidence of underdetection and undertreatment in a community population. Int J Cardiol. 2014;174:834–6. 24801084 .

5. ScientificSteeringCommitteeonbehalfoftheSimonBroomeRegister Group. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Atherosclerosis. 1999;142(1):105–12. 9920511 .

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nailfold capillaroscopy reveals early peripheral microcirculation abnormalities in children affected by heterozygous familial hypercholesterolemia;Microvascular Research;2023-07

2. Familial Hypercholesterolemia and Its Current Diagnostics and Treatment Possibilities: A Literature Analysis;Medicina;2022-11-17

3. Association Between Familial Hypercholesterolemia and Risk of Cardiovascular Events and Death in Different Cohorts: A Meta-Analysis of 1.1 Million Subjects;Frontiers in Cardiovascular Medicine;2022-06-21

4. Calcification markers and long-term outcomes of coronary artery bypass grafting;Russian Journal of Cardiology;2021-09-04

5. Hypercholesterolemia at a young age;Ateroscleroz;2021-08-10